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Abstract 
Oliver C. Pin Harry, DDS 
4-Implant supported fixed prosthesis (ISFP) in the edentulous maxilla: A pilot study on 
strategic use of short implants - Implant, prosthetic and quality of life outcomes 
Under the direction of Lyndon F. Cooper, DDS PhD 
 
Complete edentulism is a tremendous global health care burden with expected need 
for treatment to rise in the next 20 years (1). Maxillary dentures may provide 
acceptable patient satisfaction, however patients may desire a maxillary implant 
Supported Fixed Prosthesis (ISFP). ISFP‟s in the edentulous maxilla is associated 
with perceived need for grafting to support „large‟ implants (>10 mm long), large 
number of implants (6 or more) and complex prostheses. Improved access to care 
and success of therapy may involve simplification. This was a pilot study involving 
10 patients treated with four Astra Tech Osseospeed™ implants for an ISFP using a 
CAD-CAM Co-Cr framework. This study aims at simplifying therapy by avoiding or 
minimizing bone grafting and the use of short implants. Treatment efficacy and 
quality of life was evaluated with the OHIP-49 questionnaire and by documenting 
prosthetic complications and implant survival. The overall objective was to assess 
the feasibility, safety and potential of this new treatment modality.  
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PART ONE: IMPLANT AND PROSTHETIC OUTCOMES 
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1 INTRODUCTION 
 
Complete edentulism is recognized as a global healthcare burden and is associated 
with several co-morbid health factors (2). In the US, the number of adults in need of 
complete denture therapy is expected to reach nearly 38 million by the year 2020 
(1). There are three treatment choices (in addition to no treatment) available to treat 
the edentulous maxilla:  (a) conventional complete dentures (b) implant supported 
overdentures and (c) implant supported fixed prostheses (ISFP‟s). ISFP‟s may be 
fabricated using metal-acrylic, metal-ceramic or all-ceramic modalities. Treatment 
planning for ISFP‟s involve a perceived need for significant bone grafting, long 
implants (10mm or more), large number of implants (6 or more) and complex 
prostheses (3)(4). These therapies often result in increased treatment cost, time, 
morbidity and may impede access to care. This study focused on the fixed implant 
rehabilitation of the edentulous maxilla using four Astra Tech Osseospeed™ 
implants and a rigid Cobalt Chromium prosthetic framework (Metal-acrylic screw-
retained ISFP) for rigid cross-arch stabilization and splinting. The aim was to present 
a rationale for simplification of therapy with strategic and judicious placement of only 
four implants, as short as 6 mm when necessary, to avoid bone grafting and 
maximizing the confines of the patient‟s native bone in the presence of atrophied 
ridges. The working hypothesis is: A maxillary implant supported fixed denture can 
be supported by 4 implants of minimal dimension (as short as 6mm) using a rigid 
one-piece Co-Cr prosthetic framework (fabricated by CAD-CAM).  
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1.1   Challenge of ISFP’s in the edentulous maxilla 
The edentulous maxilla presents a challenge to the clinician mainly due to available 
bone quantity and edentulous ridge topography. The challenges encountered are 
mainly anatomic in nature: protruding alveolar process of the premaxilla with thin 
labial and thick palatal cortical plates, tooth loss in the posterior region is usually 
associated with vertical and horizontal bone deficiencies, but also increased 
pneumatization of the maxillary sinuses and residual ridge resorption patterns, thus 
limiting the possibilities to place implants without involving peri-implant bone grafting 
(5). Anatomic limitations direct our choices for potential implant sites if grafting is not 
included. For these reasons, implant rehabilitation in the edentulous maxilla remains 
one of the most complex therapies in prosthodontics (6). In addition there are 
numerous variables affecting esthetic and functional aspects of the prosthesis that 
should be assessed. As a consequence, treatment modalities have often included 
bone augmentation prior to or in conjunction with implant placement. Prosthodontic 
management should involve a thorough evaluation of intraoral and extraoral patient 
factors (7). These factors include: facial support, esthetic plane, maxillo mandibular 
relationship (Angle Class), lip support, smile line, vestibular space, horizontal tooth 
display, length of the upper lip (subnasal to philtrum), mucosal quality and quantity, 
incisal papilla position, speech, bone quality and quantity. These assessments may 
limit the number of available implant sites and influence the choice between a fixed 
or a removable implant supported prosthesis. 
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1.2   Contemporary treatment modalities 
In the review paper by Att et al.(5), contemporary management of fixed implant 
therapy in the edentulous maxilla is categorized in 2 groups: first, rehabilitations 
without bone augmentation and second, rehabilitations with bone augmentation.  
The first group (without bone grafting) includes 3 subcategories involving:  
(i) Regular implants defined as 10 mm in length or longer: this treatment 
modality shows a survival rate of 78% to 97.2% in the included studies 
and 88% to 100% survival rate of the prostheses over a period of 5 to 15 
years.  
(ii) Tilted implants such as the All-on-4 concept (8): Att et al. (5)included eight 
studies in this category. Implant survival rates ranged from 92.8% to 100% 
for immediate loading protocol over a period of 1 to 3 years. Conventional 
loading studies reported survival rates ranging from 97% to 99% over a 
period of 3 to 12 years. Four of the eight studies reported prosthesis 
survival at 100%. Although long-term outcomes are not available for tilted 
implants, the short term data reported appear promising. Recently, Jensen 
et al.(9) refined the tilted-implant approach without grafting describing the 
“All-on-4 Shelf” technique for the edentulous maxilla. The precept to this 
approach is to satisfy esthetic and prosthetic objectives by performing a 
prosthetically prescribed crestal bone leveling technique (“shelf”) to move 
the prosthetic/tissue junction apically to hide the junction behind the lip 
drape. This technique also offers other advantages such as increased 
restorative space, establishment of the alveolar plane, shelf width which 
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determines implant diameter and several surgical advantages including 
available bone stock source should autogenous grafting be required for 
exposed implant threads.  
(iii) Zygomatic implants: 12 studies were included for review by Att et al. 
including conventionally and immediately loaded protocols. Implant 
survival rates ranged from 93% to 100% over observation periods of 0.5 to 
12 years. Four of the studies reported prosthesis survival rates of 96% to 
100%. Biologic complications with zygomatic implants reported include 
sinusitis (2.3% to 13.6% incidence), soft tissue hyperplasia, intraoral 
infections and fistula formations. Long-term clinical trials are needed to 
provide more information on this treatment modality.  
 
The second category (with bone augmentation) includes 2 subcategories (5):  
(i) Sinus floor elevation using lateral window technique 
First presented by Tatum in 1977, this technique is based on access to the maxillary 
sinus through a lateral bone window. The sinus membrane is elevated and mobilized 
together with the bone window to allow placement of autogenous bone, bovine bone 
or bone substitute on the sinus floor. The window is then covered with a resorbable 
membrane followed by primary flap closure. Most often, a healing period of several 
months should precede implant placement. Implant survival for the delayed loading 
approach in the edentulous maxilla ranged from 82.4% to 96% over an observation 
period of 12 to 72 months. In a randomized control trial (10) comparing immediate 
versus delayed implant placement in edentulous maxillae, the 12-month survival rate 
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of immediately placed implants (1-stage: sinus grafting and implant placement) was 
significantly lower than delayed placement (implants placed after 6 months healing 
of sinus graft) (79% versus 89%). In healed sinus grafts, the survival rate of implants 
has been shown to be comparable to non-grafted sites (11,12).  
(ii) Le Fort osteotomy and interpositional bone graft 
A 11 to 16 year follow-up study was published by Nystrom et al. (13). This is a two 
stage surgical protocol to treat severely atrophied edentulous maxillae. It can be 
used with immediate or delayed implant placement. The surgical technique is 
performed with the patient under general anesthesia. Corticocancellous bone blocks 
are harvested, usually from the iliac crest. Following the Le Fort osteotomy, a 
manual downfracture is performed and interpositional bone blocks are rigidly fixated. 
The placement of implants is usually performed 6 months after reconstructive 
surgery. The miniplates and fixations screws are usually removed at the time of 
implant placement. Frequently a surgical guide is used to facilitate implant 
placement. The general complications associated with this procedure include 
unpredictable bone resorption during graft healing and exposure of the grafted bone 
in the initial healing period.  
Nystrom‟s study comprised 26 patients. At the 10-year examination, 23 patients 
were examined, 3 patients were lost to follow-up. Of 167 inserted implants, 24 failed. 
There were 19 early failures (implants lost within the first year after placement) and 5 
late failures. Two late failures occurred at the 2-year examination, two at the 3-year 
examination and one at the 5-year examination. No more failures were seen 
thereafter. The estimated implant survival rate was 85% after a mean follow-up time 
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of 13 years. All patients that were examined after 11 to 16 years (23 of 26) were still 
wearing their original fixed prostheses for a 100% prosthetic survival.  
 
Hence, several treatment modalities are presently available for the fixed 
rehabilitation of the edentulous maxilla. The decision to utilize one technique over 
others mainly depends on the quantity of available bone (9). Immediate loading of 
the edentulous maxilla may be successful in select patients (14). Patient driven 
requests for immediate function however make this approach almost impossible with 
simultaneous sinus augmentation for example.  
 
1.3   Rationale for simplification 
It appears, from a review of the literature, that ISFP‟s in the edentulous maxilla have 
often been associated with bone grafting surgeries with simultaneous or delayed 
implant placement. It is obvious that treatment time and cost tend to increase with 
such approaches. Over the past few years, protocols with angulated implants 
without grafting have become more popular (8,9).  Maxillary sinus augmentation 
procedures are often necessary in the posterior maxilla if long implants are planned 
in an upright position. Maxillary sinus grafting appears to be the most predictable 
hard tissue augmentation technique in implant dentistry(12) and long-term implant 
survival in the grafted maxillary sinus is comparable to non-grafted sites(11) but 
necessitates additional surgery, cost,  and time. In addition, patients may decline the 
procedure due to added risk and morbidity. 
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The All-on-4 concept in the maxilla utilizes four tilted implants to improve anterior-
posterior spread and avoids the maxillary sinuses. This concept has been gaining 
increased popularity due to the reduction in number of appointments and the 
possibility to immediately function. However, the majority of implants (116/128) 
utilized in a retrospective report (8) were 15 mm long  or in severely atrophied cases 
zygomatic implants (as long as 52.5mm) have been prescribed(15) – risks 
associated to surgery may therefore be heightened. The rationale for using long 
implants seems related to the need for increased primary stability which allows an 
immediate function approach. 
The strategic use of short implants (as short as 6mm) with or without tilting may offer 
the possibility to provide maximum anterior-posterior spread (A-P Spread) without 
bone grafting in select patients. In the first molar sites, sinus grafting may not be 
necessary. In the pre-maxillary sites, short implants may be placed upright or more 
lingual within the angled premaxilla ridge, facilitating prosthetic design and lingual 
access for bridge screws. In case of failure, minimal morbidity may be assumed with 
a shorter implant site which allows re-treatment immediately or within a short period 
of time. Simplification of treatment may be associated with reduced costs and 
improved access to care for patients who cannot be treated without bone 
augmentation procedures.  
Prosthetic simplification may then be achieved with less prosthetic and implant parts 
involved when only four implants are utilized without adversely affecting implant and 
prosthetic survival. A ten-year follow-up study (16) involving 156 edentulous patients 
compared ISFP‟s supported by 4 versus 6 implants (84 maxillae and 72 mandibles). 
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The survival rate for both individual implants and prostheses was the same in both 
groups at the end of the 10-year observation period. It was concluded from this 
study that the tendency of some clinicians to install as many implants as possible in 
full edentulism should be seriously questioned. 
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2 MATERIALS AND METHODS 
This study was an open prospective clinical trial to document implant survival rates, 
prosthetic performance and impact of ISFP‟s on patient satisfaction and quality of 
life. All recruited patients had an edentulous maxilla for at least two months and 
sought some type of implant therapy in the upper jaw. All patients obtained the same 
protocol of treatment which involved the initial fabrication of a maxillary complete 
denture for esthetic and functional evaluation followed by surgical placement of four 
Astra Tech Osseospeed™ implants to support a definitive maxillary metal-acrylic 
ISFP. Implants as short as 6mm were strategically used when necessary. The 
prosthetic framework was made of Cobalt-Chrome alloy fabricated by CAD-CAM 
technology (ISUS – DENTSPLY Prosthetics). Quality of life and patient satisfaction 
was assessed with the use of the OHIP-49 instrument. This clinical research study 
was submitted to and approved by the Institutional Review Board (IRB) of the 
University of North Carolina, Chapel Hill.  
 
2.1 Patient selection 
Patients seeking implant therapy for the edentulous maxilla who had interest or were 
potentially in need of a maxillary ISFP were asked to contact the investigators 
regarding possible enrollment in the study protocol. Potential patients were offered a 
screening appointment in the Graduate Prosthodontic Clinic at the School of 
Dentistry of the University of North Carolina at Chapel Hill (UNC-CH).  
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Altogether, 36 patients (16 men and 20 women) were screened. Consecutive 
enrollment of 10 patients fulfilling all inclusion criteria was completed over a period of 
five months from May to September 2009. A screening questionnaire (Appendix B) 
was used to assist in recruitment.  
The reasons for exclusion of the remaining 26 patients are listed in Table 2-1-1. 
 
Table 2-1-1: Reason for Exclusion from research study 
Reason for Exclusion Number of 
Patients 
  
Age > 80 1 
Smoker 1 
Severe Class III Skeletal 1 
Fear of Treatment 1 
Medication 1 
Financial 5 
Insufficient Vertical Bone Dimension 1 
Insufficient Facial/Lingual Bone Dimension 6 
Insufficient V & F/L Bone Dimension 9 
  
Total excluded 26 
 
All enrolled subjects were provided with an IRB approved information package 
concerning the details of the study. The overall treatment protocol and objective of 
the study was thoroughly discussed with each subject and informed consent was 
obtained prior to any treatment.  
Demographic data of the 10 subjects upon enrollment are presented in table 2-1-2. 
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Table 2-1-2: Demographic Characteristics for enrolled subjects.  
Characteristic   Statistic Subjects (N=10) 
   
Age   Mean    62.1 
   Min, Max    39.3, 78.3 
Gender    
        Males   N (%) 3 (30%) 
        Females   N (%) 7 (70%) 
Race   
        Caucasian                        N (%) 8 (80%) 
        African-American   N (%) 2 (20%) 
   
 
2.2  Inclusion and exclusion criteria 
Inclusion criteria 
Patients that could be included in the study should be aged between 18-80 at time of 
enrollment, have good physical health (ASA Class I or II), have been edentulous in 
the maxilla for at least 2 months, possess maxillary vertical bone height of at least 
5mm and 4 mm in width in the selected implant sites, no history of radiotherapy in 
head and neck region, non-smokers, and willing to give informed consent. 
 
Exclusion criteria 
Patients were excluded from the study for the following: history of radiotherapy in 
head and neck region; smokers; vertical bone height less than 5 mm and less than 4 
mm in Facial – Lingual width in any of the implant sites;  severe Angle‟s class III jaw 
relationships; psychological problems for accepting a removable prosthesis (fear, 
unwilling to wear dentures; severe gag reflex); pregnancy; steroid use; ASA Class III 
13 
 
or IV patients; uncontrolled diabetes; known alcohol and/or drug abuse; patients 
taking medication that might interfere with coagulation ( e.g. Aspirin dose of more 
than 81mg/day, Coumadin) and/or subjects with bleeding disorders (e.g. liver 
disease); patient with unrealistic esthetic expectations; lack of cooperation and 
patient with conditions that contraindicate dental implant therapy. 
 
2.3  Prosthodontic and implant treatments 
 
The study was planned to span over approximately 18 to 20 months from the first 
enrollment visit to the 12-month follow up visit.  Approximately 12 appointments were 
completed during the first 6 to 8 months of active treatment. Follow-up appointments 
were made 6 months and 12 months after delivery of the final prosthesis.  
Five patients (50%) required prosthodontic treatment of their mandibular arch as part 
of their comprehensive therapy. These treatments were rendered either prior to or in 
parallel with the research protocol.  
The total treatment time within protocol including examinations and follow-ups 
totaled an average of 15 hours and consisted of 15 appointments which are 
described below. All patients were asked to contact the investigator if they had any 
questions or concerns during the protocol.  
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Visit 1:  
Screening, examination, consent & initial records    
During this visit, screening was conducted and the questionnaire (figure 2-1-1) was 
completed by the potential subject. Following the screening process, suitable 
subjects were asked if they were interested in participating in the study. After 
thoroughly explaining details of the protocol, the patient was given the opportunity to 
read the consent form, have any questions answered, and provide consent if they 
decided to enroll in the study. All patients appointed for screening were asked to 
have a recent panoramic radiograph, the standard screening x-ray for all edentulous 
patients in the Department of Prosthodontics at UNC-CH. Medical and dental 
history, a standardized set of photographs, and preliminary impressions were 
obtained followed by extra-oral and intra-oral examinations. 
The patient was given an OHIP-49 form (Oral Health Impact Profile – 49) to fill out. 
 
Visit 2:  
Final Impressions for Complete Denture and Maxillo-mandibular relations  
Study casts were fabricated from the preliminary impressions obtained at visit 1and 
a custom tray was fabricated to obtain the final impression (Poly-vinyl siloxane) for 
the maxillary complete denture. The impression technique followed the selective 
pressure method described by Chafee et al.(17).  
Final master casts were fabricated and used for immediate fabrication of a record 
base and wax-rims to provide registration of centric relation and occlusal vertical 
dimension. The wax rims were tried intra-orally, modified in shape and contour to 
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refine the occlusal plane and provide an indication for the midline, vertical 
dimension, and position of future denture teeth. A face-bow transfer record was also 
obtained to orient the maxillary cast to the articulator. Occlusal records registered 
and confirmed the maxillo-mandibular relationship in centric relation (CR). 
Appropriate acrylic denture teeth and shade were chosen with the patient‟s 
participation.  
 
Visit 3: 
Teeth try-in on wax for Maxillary Complete Denture 
Between visits 2 and 3, the maxillary master cast was mounted on a semi-adjustable 
articulator using the face-bow record. The selected denture teeth (Ivoclar Blue line) 
were set on the wax-rims / record base and finished for clinical try-in during this visit. 
The teeth set-up on wax was tried clinically and teeth positions were modified and 
refined to meet esthetic, phonetic and occlusal objectives. Esthetic approval was 
confirmed with the patient in order to proceed to completion of the maxillary 
complete denture.  
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Visit 4: 
Delivery of maxillary complete denture and fabrication of surgical/radiologic guide  
A thin layer of pressure indicator paste was applied onto intaglio surfaces of the 
maxillary denture before insertion in the patient‟s mouth to locate pressure spots. 
Any pressure spots, overextensions and sharp edges were trimmed and relieved. 
The patient was guided to close into CR position and any prematurity or deflective 
contacts in CR were identified. Occlusal corrections, if any, were accomplished after 
remounting the denture on the articulator. Patients were asked to contact the 
Graduate Prosthodontic Clinic if they experienced any discomfort with their new 
prosthesis. None of the patients requested a visit for denture adjustments.  
A surgical/radiologic guide was fabricated by duplicating the maxillary denture with 
clear cold-cure radio opaque acrylic resin (Biocryl-X). The guide was also tried in the 
patient‟s mouth to confirm adequate fit and acceptable occlusion.  
 
  
 
 
 
Figure 1.1: Complete denture duplicated in radio-opaque surgical/radiologic guide (Biocryl X™) 
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Visit 5: 
Cone Beam Computed Tomography to evaluate implant sites and surgical approach 
 
 
This visit was completed with the co-operation of the Oral Maxillofacial Radiology 
clinic at UNC-CH. Patients were evaluated three-dimensionally by Cone Beam 
Computerized Tomography (CBCT) to identify contours of the maxillary sinus in 
relation to anticipated implant sites as well as potential implant sites (canines and 
first molars) . The guide was placed in the patient‟s mouth and a CBCT was 
obtained. This is a standard procedure for three dimensional evaluations of anatomic 
structures in proximity to the implant sites and the volume of bone available prior to 
surgical placement of implants. The chosen implant sites were then marked and 
located on the guide. For nine of the ten patients (90%), visits 4 and 5 were 
completed on the same day. 
 
 
 
 
Figure 1.2: Individual implant site analysis with Facilitate™ software  
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Visit 6: 
Implant placement surgery 
Patients were pre-medicated with 2 g of Amoxicillin (600 mg of Clindamycin if 
penicillin allergy). The antibiotic prescription was extended for a period of 7 days 
postoperatively. Immediately before surgery, patients were given perioral lavage with 
0.12% Chlorexidine Digluconate solution. A sterile surgical set-up was utilized 
throughout this appointment. Topical anesthetics was applied to the oral mucosa of 
the maxillary vestibule and maintained for one minute. Infiltration anesthesia using 
2% lidocaine with epinephrine 1/100,000 was provided to the maxilla. On average, 
7.2 ml (4 carpules) of anesthetic was required.  
 
 
Figure 1.3: Direction indicators placed in 
osteotomy sites demonstrating angulation 
and A-P spread of four maxillary implants 
Figure1.4: Cover screws placed prior to 
suturing 
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With the surgical guide in place, the planned implant positions were marked with an 
indelible marker (Thompson Marker). A mid-crestal incision extending 5 mm past the 
posterior implant sites was made with a #15 blade and full thickness muco-periosteal 
flap elevated. Implant site preparation is accomplished using an electric implant 
motor with a maximum speed of 1500 rpm and external irrigation of sterile saline 
water according to the Astra Tech surgical manual. The drill sequence was adjusted 
according to the surgical manual to accommodate different implant width and length. 
Round end osteotomes were used to prepare implant sites in areas of low bone 
density or minimal facial-lingual dimension. In the implant sites where an osteotome 
sinus elevation was indicated prior to implant placement, a concave osteotome 
corresponding to the implant being placed was used to elevate the sinus floor 
following the technique described by Fermergard et al. (18) 
All implants were placed using an electric handpiece and good primary stability was 
obtained. One patient (1 of 10) was treated using a flapless guided surgery protocol 
(Astra tech Facilitate – Figure 1.6) followed by placement of healing abutments. The 
remainder of the subjects (9 of 10) received a two –stage surgical approach. Cover 
screws were placed and primary flap closure obtained with 4.0 chromic gut sutures.  
Figure 1.5: Primary wound closure with 
continuous 4.0 chromic gut suture. 
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Figure 1.6: Implant placement using flapless guided surgical approach (Astra Facilitate™) 
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Some implants displayed exposed threads on the facial aspect and autogenous 
bone collected from the osteotomy of the implant sites or alveolectomy sites were 
placed on the exposed threads. All implants with exposed threads were in the pre-
maxillary sites.  
Of the 40 initially placed implants in the 10 patients, only 17 sites were 
straightforward. The standard drill sequence was followed, implants were placed 
with the surgical handpiece and good primary stability was achieved. 
The remaining 23 implants required some site manipulation: osteotome sinus lift, 
osteotome lateral site expansion and/or bone graft collected from osteotomies. 
For 1 posterior site and 1 anterior site on the same patient (#1), a barrier membrane 
(Biogide) was used in conjunction with the bone grafts.  
For most pre-maxillary sites, with limited facial-lingual dimension, the drill sequence 
was used up to the 3.2 mm twist drill and osteotomes (3.2mm to 3.7 mm) were used 
to expand the osteotomy prior to implant placement. 
For 1 posterior site, an osteotome sinus elevation was performed. 
For 3 posterior sites on 2 patients, the sinus floor and membrane were inadvertently 
perforated during the osteotomy.  
Table 2-3-1 summarizes site specific manipulation performed for each subject.  
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Table 2-3-1 Site specific summary during fixture placement.  
Patient 
I.D # 
Posterior Right Anterior Right Anterior Left Posterior Left 
1  
Straight-forward 
 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
 
Straight-forward 
 
2 Straight-forward 
 
Osteotome 3.2-3.7 Osteotome 3.2-3.7 Straight-forward 
 
3 Straight-forward 
Flapless Guided 
Straight-forward 
Flapless Guided 
Straight-forward 
Flapless Guided 
Straight-forward 
Flapless Guided 
4 Sinus floor 
perforation 
Straight-forward 
 
Straight-forward 
 
Straight-forward 
 
5  
Straight-forward 
 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
 
Straight-forward 
 
6 Sinus floor 
perforation 
Bone graft from 
osteotomy sites 
Bone graft from 
osteotomy sites 
Sinus floor 
perforation 
7 Osteotome sinus lift Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
8 Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
9  
Straight-forward 
 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
 
Straight-forward 
 
10 Osteotome 3.2-3.7 Bone graft from 
osteotomy sites 
Bone graft from 
osteotomy sites 
Osteotome 3.2-3.7 
 
Peri-apical radiographs of each implant placed were obtained as baseline for future 
comparison of crestal bone levels. The patient‟s dentures were relieved and relined 
where necessary with a temporary soft liner. Standard written post-operative 
instructions were provided to all patients. 
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All implants were 4.0 mm diameter and the length and distribution are summarized 
in table 2-3-2 
Table 2-3-2 Implant length (mm) and distribution       
Patient ID # 
Posterior 
Right 
Anterior 
Right 
Anterior 
Left 
Posterior 
Left 
1 8 8 8 8 
2 9 9 9 9 
3 9 9 9 9 
4 9 11 9 9 
5 6 8 8 6 
6 9 11 11 11 
8 8 11 6 8 
9 8 8 8 8 
10 9 6 6 9 
 
Mean implant length for total of 36 implants = 8.5 mm  
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Visit 7:   
Post-operative 1 week to 2 weeks after implant placement 
 
During this visit, soft tissue healing was assessed. Any excessive pressure areas 
from the maxillary denture were verified and relieved as deemed necessary. All 
patients reported using pain medications for 3 days or less and reported that 
discomfort improved and became acceptable within 1 week following surgery.  
Visit 8:   
Post-operative 4 weeks after implant placement. 
 
This visit was for the assessment of soft tissue healing and to check for any 
pressure areas from the wear of the maxillary denture. These areas were relieved 
Figure 1.7: One week after implant placement 
Figure 1.8: Four weeks after implant placement 
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and adjusted extra orally as deemed necessary. All patients reported good comfort 
and three required additional interim soft reline to improve retention of their maxillary 
dentures.  
 
Visit 9:  
Final Abutment level impressions 8-20 weeks after implant placement.  
Framework design / wax-up & set-up in the laboratory 
During this visit, the implants were exposed (stage 2 surgery) under local anesthesia 
and appropriate abutments (Uni-abutment 20 degrees, angled or uni-abutment 45 
degrees) were connected to the implants. The exposure of the implants was 
facilitated with the use of the surgical guide used during fixture installation (visit 6). 
This allowed a short crestal incision of 5 to 6 mm or less – this minimally invasive 
approach allowed for straight-forward abutment impressions during the same 
appointment.  
 
Figure 1.9: Twelve weeks after implant placement 
Patient to receive stage-2 surgery and abutment 
installation 
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Each abutment was torqued according to manufacturer‟s specification (Astratech 
manual). Impression copings were connected to the abutment and a full-arch PVS 
impression was made. Closed tray abutment transfers were primarily used except 
for angled abutments that necessitated an open tray transfer.  
 
Figure 1.12: Abutment transfer copings in place 
 
Figure 1.10: implant sites marked prior to incision 
 
Figure 1.11: installed prosthetic abutments 
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The master cast accuracy was verified with a resin jig fabricated with light-cured trial 
tray material and temporary titanium cylinders.  
 
The cured resin was left on the master cast for at least 1 hour before trial clinically. 
All master casts (8 patients who received their definitive ISFP) had acceptable 
accuracy.  
 Table 2-3-4 Type and distribution of prosthetic abutments       
Patient ID # 
Posterior 
Right 
Anterior 
Right 
Anterior 
Left 
Posterior 
Left 
1 20/3 A/6 A/11 20/14 
2 20/3 20/6 20/11 20/14 
3 20 /4 20/7 20/10 20/13 
4 45/4 20/6 A/11 45/13 
6 20/3 A/7 A/9 45/14 
8 20/3 A/7 A/11 20/14 
9 20/5 20/7 20/10 20/13 
10 20/3 A/7 A/11 20/14 
Abutment Type / Implant Position 
20 = Astra Straight 20-degree uni-abutment 
45 = Astra Straight 45-degree uni-abutment 
A = Astra angled abutment 
 
Figure 1.13: Verification Jig 
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The initial goal during planning and fixture placement was to exclusively use 20-
degree uni-abutments, however, ridge morphology and available bone dictated 
implant angulations beyond what would be tolerated by straight 20-degree uni-
abutments without having screw accesses through the facial of prosthetic teeth. This 
was particularly challenging in the anterior region in spite of the use of short 
implants. Hence angled and straight 45-degree uni-abutments were indicated in 
some cases.  Tables 2-3-4 and 2-3-5 summarize the type and distribution of 
abutments used for the 8 patients that completed treatment. Angled abutments were 
required for 9 implants all in the pre-maxilla for 5 of the 8 patients that received their 
definitive ISFP.  
Three 45-degree uni-abutments were required for severely angulated implants in the 
posterior maxilla for 2 of 8 patients that received their definitive ISFP.  
Altogether, only 3 of 8 patients were restored exclusively with straight 20-degree uni-
abutments. These 3 patients presented with the most favorable ridge volume and 
morphology – 1 of these 3 patients had all 4 implants placed using a flapless guided 
surgical technique.  
 
Table 2-3-5 Percentage of abutments by type 
Abutment n % Note 
Angled 9 28 All in premaxilla 5 of 8 patients 
20-Degree Straight Uni-abutment 20 63 Used exclusively on 3 of 8 patients 
45-Degree Straight Uni-abutment 3 9 All in posterior maxilla 2 of 8 patients 
TOTAL  32 100  
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Visit 10: 
Framework try-in, verification of fit and Maxillo-Mandibular relationship 
 
 
Between visits 9 and 10, a Cobalt-Chrome framework was fabricated using CAD-
Cam technology (DENTSPLY – ISUS Prosthetics). The maxillary master cast was 
provided with a duplicated denture made of Bis-acryl. This duplicate provides the 
outer outline of the definitive prosthesis and hence, permits adequate design of the 
prosthetic bar, tooth supports, and maximizes the use of available restorative 
dimension.  
 
 
Figure 1.14: Duplicated denture in Bis-Acryl for framework design 
 
Figure 1.15: Digital conception and design of prosthetic framework (DENTSPLY ISUS) 
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At this visit, Pro-Heal Caps were removed from all 4 abutments. The Cobalt-Chrome 
milled framework was tried on the abutments to determine acceptable fit.  
 
 
Four methods described in the results section were used to assess passive 
framework fit. Once passive fit was confirmed, a CR bite registration was obtained 
with the framework in place, using a PVS (Regisil), at the same vertical dimension of 
occlusion as the complete removable denture. The Pro-Heal caps were secured 
back on the abutments. The patients left with their complete dentures. 
 
Visit 11: 
Teeth and wax try-in 
Between visits 10 and 11, the mandibular cast was mounted to the maxillary frame / 
occlusal registration assembly. Ivoclar Blue line (6 of 8 ISFP‟s) or Phonares (2 of 8 
ISFP‟s) Denture Teeth were set on the framework using base plate wax.  
 
Figure 1.16: CAD-CAM Cobalt-Chromium Framework – Verification of passive fit 
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Tooth position as determined on the complete denture was used as reference for the 
set-up. During this visit, the teeth wax-up was tried on the patient for esthetics and to 
confirm CR. Teeth were repositioned on the wax as deemed necessary based on 
esthetics and phonetics. Patient approval was obtained prior to proceeding.  The 
patients left with their complete dentures.  
 
 
  
Figure 1.17: Wax-up on master cast and clinical try-in 
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Visit 12: 
Delivery of final prosthesis 
 
 
 
Following removal of Pro-Heal Caps, the final ISFP was placed on the implants and 
the screws hand tightened. The occlusion was then verified and adjusted 
accordingly. After all necessary adjustments are made the prosthesis was  polished; 
bridge screws were tightened to 15 Ncm using the AstraTech calibrated hand 
Figure 1.18: Definitive ISFP 
Occlusal and Frontal view 
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wrench. All screw access holes were closed with a cotton pellet on each screw and 
using a light cured composite material.  
 
Visit 13: 
Post op 1-2 weeks after delivery of final prosthesis.  
The occlusion, function and phonetics of the fixed prosthesis were evaluated. 
Adjustment to the occlusion if necessary was completed intra-orally with a hand 
piece and acrylic bur and polished accordingly. OHIP-49 form (19) was administered 
to the patients.  
 
Visit 14 and 15:  
Post-Delivery ISFP - 6 months & 12 months 
At both visits, the patients were given an OHIP-49 form (19)(Oral Health Impact 
Profile – 49) to complete. The prosthesis was thoroughly evaluated at this 
appointment. The occlusion, function and prosthesis integrity was verified.  
All four implants were examined and evaluated and one periapical radiograph was 
taken for each implant.  
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3 RESULTS 
Implant and Prosthetic data are reported for the 10 patients enrolled in this study. At 
time of reporting (3/23/2011), the status of the subjects were as follows: 
- 8 of the 10 patients received their definitive ISFP. (8 had a 2 week follow-up, 
7 had a 6-month follow-up and none had a 1-year follow-up) 
- 1 patient is at the stage of definitive ISFP fabrication 
- 1 patient (#7) will not able to obtain the definitive ISFP because of cluster 
failure of all four of her initially placed implants. 
Table 3-1 summarized the status of each patient in the study protocol. 
Table 3-1: Summary status of each patient in protocol 
Patient ID ISFP installed 2-week FU 6-month FU 12-month FU 
1 Completed Completed Completed In progress 
2 Completed Completed Completed In progress 
3 Completed Completed Completed In progress 
4 Completed Completed Completed In progress 
5 In progress In progress In progress In progress 
6 Completed Completed Completed In progress 
7 Implant Failures N/A N/A N/A 
8 Completed Completed In progress In progress 
9 Completed Completed Completed In progress 
10 Completed Completed Completed In progress 
 
 
 
 
35 
 
3.1 Implant outcomes 
3.1.1 Implant Survival 
Patient #7 was excluded from the implant survival data based on medical reasons 
that were not evident at the time of enrollment (see implant complications). A total 
number of 39 implants were installed on 9 patients (36 fixtures placed initially and 3 
failed fixtures replaced after removal). Implant survival was defined (20)as the 
implant still in place and functioning in the mouth.  
If preloading failures of the 3 fixtures are included in the survival analysis, this 
accounts for a 92.3 % survival rate.  
Implant survival rate after abutment and prosthesis delivery was 100 %.  
No patients were lost to follow-ups at time of reporting.  
 
3.1.2 Implant Complications 
Preloading failures were predominantly in the premaxilla. A total of 3 patients 
(Patients #‟s 5, 7 and 8) lost one or more implants between placement and 
prosthesis loading.  
Patient #5: at stage 2 surgery about 3 mm bone loss was found on both 6 mm 
anterior implants – this was confirmed with periapical radiographs. One of the 
anterior implants was loose. Both implants were removed and the sites were grafted 
with Bio-oss & Bio-gide and allowed to heal. Two 8 mm implants were placed 4 
months after healing. These implants have integrated and the patient is awaiting 
delivery of her final prosthesis at time of writing. 
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Patient #8: contacted the investigator and presented with a loose implant in the right 
anterior at stage 2 surgery. The implant was removed and a new 11 mm implant was 
placed a few weeks after its removal. Bio-oss and Bio-gide were used to graft the 
site with simultaneous implant placement. This implant integrated and the patient 
has already received her definitive ISFP.  
Patient #7: this was a cluster failure situation. The patient lost all her 4 initial 
implants over a period of 20 weeks following placement. The first implant (#11 – 8 
mm long) came loose and was replaced with a 9 mm implant in conjunction with a 
Bio-Oss™ and Bio-Gide™ graft. A few weeks later, the three other implants were 
either removed due to infection or severe bone loss (#‟s 14 and 6) or came loose 
(#3) over a period of 5 weeks. The replaced #11 implant is the only one surviving at 
time of reporting. The last three implants lost (#3, 6, 14) were not replaced after loss 
or removal.  
 
3.2 Prosthetic outcomes 
3.2.1 Fit and accuracy of CAD-CAM Co-Cr prosthetic framework 
Brånemark (21) stated that achieving passive fit between implant frameworks and 
underlying structures is critical for successful long-term osseointegration. Ill-fitting 
framework may also be associated with mechanical and technical failures of ISFP‟s. 
Common mechanical complications include loosening or fracture of prosthetic 
abutment screws (22). Acceptable levels of fit vary greatly in the literature, ranging 
from 10 microns (21) to 150 microns. The later value was reported by Jemt (23) who 
defined passive fit as a level that did not cause any long-term clinical complication. 
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This corresponds to less than half-a-turn to completely tighten the gold screw after 
its initial seating resistance was encountered.  
Several methods have been described to evaluate implant framework fit and 
passivity (24).  
Four methods were utilized to assess framework fit in the present study:  
(i) Alternate finger pressure: this is a simple method for initial macroscopic 
assessment of framework fit by manually seating the framework with 
finger pressure applied alternatively over 1 terminal abutment and then the 
other. Any rocking or fulcruming would denote an unacceptable fit.  
(ii) Direct vision and tactile sensation: this method can be enhanced with 
excellent lighting and magnification, however may be limited by margin 
location and size of explorer tip.  
(iii) One-screw test: for this method, 1 screw is tightened at one terminal 
abutment and discrepancies observed at the other abutments. This 
technique is particularly effective in long span frameworks. The one-screw 
test is often combined with direct vision and tactile sensation. 
(iv) Screw-resistance test: introduced by Jemt in 1991 based on his 
experience that a clinically acceptable level of misfit was 150 microns, 
which corresponds to half the distance between the Nobel Biocare 
prosthetic gold screw threads. Gold screws are tightened one by one 
starting with the implant closest to the midline until initial resistance 
between the head of the screw and the framework is encountered. A 
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maximum of a half turn (150 microns) was then allowed to completely seat 
the screw.  
 
Altogether, 8 frameworks were tried, installed, and successfully demonstrated 
clinically acceptable fit using all four testing modalities at first attempt.  
Table 3.2.1.1 summarizes the results of the different tests. 
Table 3.2.1.1 Summary of tests – Framework Fit 
Patient I.D #  1 2 3 4 6 8 9 10 
Alternate finger pressure ok ok ok ok ok ok ok ok 
Visual and Tactile ok ok ok ok ok ok ok ok 
One-screw test ok ok ok ok ok ok ok ok 
Screw resistance test (turns) <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
 
 
3.2.2 A-P Spread and Cantilever Values 
Using a theoretical mathematical model, Skalak (25) concluded that cantilevered 
ends of an ISFP increases the loading on the first screw nearest to the cantilevered 
end and that moderate cantilevers may be tolerated provided the fixtures are 
sufficiently strong. Based on theoretical geometric consideration and clinical 
experiences with the Brånemark System, Rangert (26) provides simple guidelines 
for controlling occlusal loads on implants and prosthetic reconstructions – an A-P 
spread (distribution distance between the most anterior and most posterior implants) 
of 10mm was proposed for a cantilever of 20 mm (2 x A-P spread)  for mandibular 
ISFP‟s. English (27) proposed anecdotally that a very reasonable rule of thumb for 
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determining posterior cantilever in mandibular ISFP‟s should be 1.5 times A-P 
spread. According to English, this would allow a 10-12 mm posterior cantilever for 
the mandible whereas maxillary ISFP posterior cantilevers should be reduced to 6-
8mm due to lower bone density. Taylor (28) suggests that cantilevers greater than 
10-12 mm may be overloading factors for ISFP‟s in the edentulous maxilla. A 
systematic review, Salvi et al.(29) appraised the literature relating the impact of 
mechanical/technical risk factors on implant-supported reconstructions. The authors 
conclude that presence of cantilever extension(s) greater than 15 mm and the length 
of the reconstructions were associated with increased mechanical and technical 
complications. In one of the included studies, Shackleton et al. (30)retrospectively 
analyzed the effect of cantilever extensions in ISFP‟s for 25 patients (28 ISFP‟s: 24 
mandibles and 4 maxillae) and concluded that ISFP‟s with cantilevers of 15mm or 
less had survived significantly better than ISFP‟s with greater than 15 mm of 
cantilever.  
Reported guidelines for cantilever extensions appear to be referenced to (i) a 
maximum acceptable value which tends to be greater in the mandible compared to 
the maxilla and (ii) a multiplying factor of the A-P spread providing individualized 
patient dependent values.  
In a 15-year follow-up study of 76 patients treated with ISFP‟s in the edentulous 
maxilla, posterior cantilever values ranging from 7 to 12 mm were reported. A review 
of published maxillary ISFP‟s studies revealed that anterior cantilever values have 
not been previously reported.  
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The authors of the present study speculate two possible explanations: (i) forces of 
occlusion are higher in the posterior areas and, by extension, cantilevers in the 
anterior regions may not contribute to stress on ISFP‟s, hence reducing its 
significance (ii) ISFP‟s in the edentulous maxilla are traditionally supported by more 
than 4 implants with more implants distributed in the premaxilla.  
 
With the use of 4 implants in the present study (canine and first molar position), we 
have found that anterior cantilevers may have significant values sometimes 
exceeding posterior cantilever values in the same patient.  
For each ISFP, one anterior cantilever value (A) was measured using the most 
anterior tooth on a perpendicular from the line joining the two anterior implant 
abutments and two bilateral posterior cantilever values (P(Rt) & P(Lt)) were 
measured. The mean anterior cantilever value was 10.1 mm (range of 7 to 15mm) 
and the mean posterior cantilever value was 10 mm (range of 2 to 16mm).  
Table 3-2-2-1 lists the cantilever values for 8 subjects who received their ISFP. 
 
The A-P spreads were measured bilaterally for the 8 subjects that have received 
their definitive ISFP. The right and left A-P spread values were obtained by 
measuring the distance between the implant abutments on the definite master casts 
and reported in table 3-2-2-2 
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Table 3-2-2-1 Anterior and posterior cantilever values in (mm) 
Patient ID # Anterior  Posterior(Rt) Posterior(Lt) 
1 14 13 13 
2 15 2 2 
3 9 16 12 
4 12 12 11 
5 Treatment in progress 
 
6 7 5 5 
7 Excluded  from study 
 
8 7 9 9 
9 8 13 10 
10 9 14 14 
Mean (mm) 10.1 10.5 9.5 
 
 
Table 3-2-2-2 Anterior-Posterior (A-P) values in (mm) 
Patient ID # 
A-P 
Spread 
Right 
A-P 
Spread 
Left 
1 18 15 
2 16.5 16 
3 18 16 
4 13.5 14.5 
6 26 26 
8 22 17 
9 11 11 
10 20.5 14 
Mean A-P Value 
(mm) 18.2 16.2 
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3.2.3 Anterior horizontal and vertical overlap 
Anterior horizontal and vertical overlap has not been reported in clinical studies on 
ISFP‟s. The authors hypothesize that minimal anterior vertical overlap should be a 
clinical goal to minimize fracture of acrylic veneer or denture teeth. During chewing 
function, the mandibular anterior teeth may impart eccentric horizontal forces 
causing technical failure/fractures of the maxillary anterior acrylic teeth. Minimal 
vertical overlap may offer a significant advantage to minimize horizontal forces on 
the maxillary anterior teeth. In a review article, Kim et al.(31) propose group function 
occlusion or mutually protected occlusion with shallow anterior guidance when 
opposing natural dentition.  
The distribution of occlusal function during protrusive movement may also have 
some merit in maximizing occlusal load on several teeth. In the present study, mean 
values of vertical and horizontal overlap are presented (Table 3-2-3-1).  
 
Table 3-2-3-1 Vertical and Horizontal Overlap 
Patient ID # 
Vertical  
Anterior Overlap 
Horizontal  
Anterior Overlap 
1 3 3 
2 1 1 
3 4 2 
4 2 3 
6 1 1 
8 2 3 
9 3 4 
10 2 3.5 
Mean Value (mm) 2.3 2.6 
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The authors have also made every effort to minimize vertical overlap (shallow 
anterior guidance) and to provide anterior group function on protrusion. It should be 
noted that the only resin tooth fractures encountered in the study population was 
observed on the subject presenting the highest vertical overlap (Patient #3 = 4 mm) 
and opposed natural dentition.  
3.2.4 Prosthetic Complications 
Prosthetic complications were minimal and could easily be managed during the 
same visit. In the present study, two technical complications were observed: (1) an 
acrylic tooth came loose and was repositioned with repair acrylic and (2) a small 
incisal chip was noted on another acrylic tooth, the chip was not noticed by the 
patient – the chip was too small to justify replacement and was therefore smoothed 
with patient‟s consent. Both technical complications were observed on the same 
patient (#3). It may be worthy to note that the opposing dentition was fixed/natural 
dentition.  
 
 
No prosthetic/abutment screw loosening/fractures or other prosthetic/technical 
complications were observed over the observation period of up to one year.   
Figure 1.19: Patient #3 – Prosthetic Complications  
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The most prevalent prosthetic complication associated with metal-acrylic ISFP‟s is 
acrylic veneer/tooth fracture (22). Less frequent complications include 
loose/fractured prosthetic and abutment screws and framework fractures. One study 
(23) identified a significantly higher ratio of problems in maxillary ISFP‟s than in 
mandibular ISFP‟s. Fractures of resin teeth were more common problems in the 
maxillary ISFP‟s.  
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4 DISCUSSION 
This new treatment approach with 4 implants showed successful short-term 
outcomes in select cases and implant failures in a three of the 10 subjects. Implant 
failures occurred predominantly in the premaxilla between implant placement and 
abutment installment. Complications were minimal after prosthesis loading and were 
technical in nature (acrylic teeth fracture).  
 
Other studies compared tilted and axial placement of implants. Number and length 
of implants, implant failures encountered, the evolution of ISFP‟s, prosthodontic 
planning as it related to A-P spread and cantilevers, and finally strengths/limitations 
of the present study will be discussed.  
 
Tilted versus axial implants 
Aparicio et al. (32)studied the use of a combination of tilted and axial implants with 
severely resorbed maxillae as an alternative to sinus grafting. 25 patients were 
restored with 29 fixed partial dentures supported by 101 implants (59 axial and 42 
tilted). They reported 100 % cumulative implant survival rate for the tilted implants 
and 96.5% for the axial implants. All prostheses except two were stable at the fifth 
year follow-up. 18 abutment screws, 5 gold screws in a total of 14 prostheses 
needed retightening. 2 abutment screws and 2 occlusal surfaces fractured. This 
suggests that the use of tilted implants to avoid sinus grafting in the posterior maxilla 
is an effective approach with some technical complications related to fracture or 
loosening of gold screws and abutments.  
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Malo et al. (8) applied the “All-on-4” immediate function concept with long angled 
implants within the anatomic limitation of the edentulous maxilla and reported a 1-
year cumulative survival rate of 97.6%.  
Rosen et al. (33) in a long-term follow-up study placing 4 to 6 tilted implants in 
severely resorbed edentulous maxillas on 19 patients (total of 103 implants) reported 
a survival rate of 97%. The mean follow-up time  was 10 years, demonstrating that in 
patients with severely resorbed maxillas may be treated successfully with tilted 
implants as an alternative to more resource-demanding techniques with bone 
grafting.  
Astrand at al. (34) in a 20-year follow-up study recalled 21 patients with a total of 23 
ISFP‟s – all patients were treated ad modum Branemark. Most prostheses in the 
upper jaw were supported by 4 implants while 6 implants were used in the mandible. 
The choice of 4 maxillary implants was because of restricted bone volume. In the 
reported patient group, the implant survival rate was 99.2%. This group, however, is 
part of a larger group of 48 patients treated over 20 years ago. Technical 
complications were few and easy to take care of since the prostheses were screw 
retained. Jemt et al, (35) reported in a 15-year follow-up study on 28 patients 
examined (168 implants) with ISFP‟s in the edentulous maxilla. The ad modum 
Branemark protocol was used for this study also. They reported a 90.9 % cumulative 
survival rate and prosthetic complications were related to fractures (14 resin 
veneers, 1 framework and 1 gold screw).  
From these studies, it may be concluded that survival rates of tilted implants remain 
comparable to axially placed implants. Abutment/screw loosening and fractures are 
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related to implant supported prostheses, however the rate of these complications 
seem to increase on tilted implants. 
 
Number and length of implants (short) 
Implant size and number in the present study may be controversial. The concept of 
using implants of small dimension (short) and in small numbers (four) to support a 
full arch fixed prosthesis in the edentulous maxilla defies conventional treatment 
planning whereby at least 6 implants(4) or even 8 to 10 implants(7) have been 
advocated.  
When Brånemark (21) introduced osseointegration to North America, he suggested 
that a minimum of four fixtures appears to be adequate for support of a full arch 
prosthesis in the edentulous jaw. However, if morphologically feasible, six fixtures 
are installed to provide a certain reserve should a fixture not become integrated or 
lose its integration over the years. 
Short implants (6 - 8.5 mm) in posterior segments of severely atrophied maxillae 
have demonstrated cumulative survival rates of 94.6% for an average follow-up of 
37.6 months for the 85 patients with 96 implants supporting single-tooth and partial 
reconstructions(36).  
High Crown/implant ratios may also be a subject of discussion. The use of short 
implants inevitably increase crown/implant rations which may be perceived as 
unfavorable for both implants and restorations. Blanes et al. (37) in a long-term 
prospective study on 192 implants showed that implant restorations with high 
Crown/implant (C/I) ratios greater than 2 showed a cumulative survival rate of 
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94.1%. Within the limitations of the study, they concluded that implant restorations 
with high clinical C/I ratios do not demonstrate lower survival or success rates as 
compared with implant restorations with low C/I ratios. As a result, the use of implant 
restorations with C/I ratios of 2–3 may be successful in the posterior region of the 
mouth. 
In the present study, four implants, no longer than 11mm and as short as 6 mm, 
were utilized for a mean implant length of 8.5 mm. This approach allowed placement 
of fixtures in patients with limited ridge dimension and so-called unfavorable sites. 
Implant angulations were kept within prosthetically manageable limits and axial 
placement was achieved in most posterior sites. Another noticeable advantage of 
this modality was the ability to provide excellent A-P spread and acceptable 
cantilever values even when second molar replacement was provided. This will be 
further discussed later.  
 
Implant failures 
In the present study, several implant losses were experienced. All failures occurred 
between initial implant placement appointment and stage-2/abutment installation 
appointment and were predominantly in the premaxilla (5/7). One patient (#7) lost all 
4 initial implants accounting for the 2 posterior implants lost in the study.  
In a descriptive analysis (38) of implant and prosthodontic survival rates with fixed 
implant-supported rehabilitations in the edentulous maxilla. The 1 to 15-year survival 
rates of fixed implant rehabilitations in the edentulous maxilla was reviewed. Thirty-
three studies, including 1,320 patients and 8,376 implants, were selected for 
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analysis. The overall calculated implant survival rates ranged from 94% (1 year) to 
87.7% (15 years). Two conclusions from this study: (i) Implants placed in augmented 
bone had a statistically lower survival rate, except for rough-surface implants, for 
which no statistical difference between augmented and non-augmented bone 
survival rates was found and (ii) Implant number and distribution along the 
edentulous maxilla seemed to influence the prosthodontic survival rate. When 
comparing the number of implants per edentulous maxilla, protocols with 6 or more 
implants showed higher prosthetic survival than protocols with less than 6 implants. 
there was a trend at each time point without statistical significance. Implant-
prosthetic protocols with an anterior-posterior implant distribution resulted in 
statistically significant higher prosthodontic survival rates compared to those with an 
anterior implant allocation design. From this review, it appears that increased A-P 
spread seems to improve prosthesis survival.  
For the present study, 3 patients lost 5 pre-maxillary implants. 3 of 5 implants were 
replaced after grafting the sites with Bio-oss/Biogide. One patient (#8) presented 
with a loose anterior implant: the implant was removed and replaced in conjunction 
with grafting. For the second patient (#5), the two premaxillary implants were 
removed the sites were grafted. The implants were replaced after 4 months of 
healing. The third patient (#7) lost all 4 of her initially placed implants and was 
unable to complete the protocol. All 3 patients (#‟s 5, 7, 8) initially presented with 
less than 5mm of Facial-lingual bone dimension at the implant sites, requiring the 
use of osteotomes for site expansion and placement of bone collected from the 
osteotomy sites.  
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These observations could suggest that: (i) a minimal facial-lingual dimension of 6 
mm may be required for placement of 4mm diameter implants and (ii) deficient 
premaxillary sites (< 6mm facial-lingual dimension) may benefit from bone grafting at 
the time of implant placement or delayed placement of implants in the healed grafted 
sites. Although none of the 10 enrolled subjects in the present study had unfavorable 
maxillomandibular relationships, the patients that experienced implant losses prior to 
implant loading, had limited facial-lingual bone dimensions in the premaxilla. 
However, other patients in the protocol (#‟s 1, 2, 9, 10), also with limited bone 
dimensions did not experience implant failures prior to implant loading.  
Zitzmann and Marinello (7) discussed that if a treatment planning protocol 
considering anatomic patient factors (among other considerations) is followed, 
implants can be placed to comply with the selected prosthetic solution (fixed or 
removable) and compromised solutions may be averted. They conclude that the 
fixed design for implant prosthesis is only appropriate for patients with minimal 
resorption of the alveolar bone and an optimal maxillomandibular relationship.  A 
removable overdenture may be indicated from the outset and is no longer restricted 
to patients with a compromised situation in which fixed implant prostheses are not 
feasible.  
Evolution of ISFP’s 
ISFP‟s have evolved and changed over the years. Maxillary and mandibular ISFP 
concepts and design were originally dependent on available bone and placement of 
axial implants anterior to the maxillary sinus and between the mental foramen in the 
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mandible. Cantilevers as much as 15 mm were not unusual. The cantilever problem 
was resolved with the evolution of distributed implant placement. To achieve better 
A-P spread and distribution, implants were tilted. This concept still enabled 
placement of longer implants that avoided anatomic structures and provided 
sufficient primary stability for immediate function. The effects of angulated implants 
include reduced cantilever values, required use of angulated abutments in most 
cases and possible increased occurrence of loose and fractures abutments/screws.  
Prosthetic frameworks in ISFP‟s have also undergone noticeable evolution. The 
original ad modum Branemark prostheses utilized cast gold alloy frameworks. Long-
term studies have reported framework fractures although rare. Ortorp et al., in a 10-
year comparative clinical study showed that milled titanium framework were 
comparable to cast gold frameworks and offered an alternative for full arch ISFP‟s. 
there were a total of 3 framework fractures (1 Titanium and 2 Gold) reported at 
follow-up from a total of 72 ISFP‟s (37 mandibles, 35 Maxillae) examined at 10 
years.  
The present study utilized a CAD-CAM Cobalt-Chromium which is a stronger metal 
than titanium. The framework design incorporated individual extensions (tooth–
supports) that may minimize acrylic fractures and provide enhanced support to the 
acrylic prosthetic teeth and pink veneering acrylic. Adequate cross-sectional 
framework dimensions and contour were well controlled prior to fabrication by using 
a three-dimensional viewer software. The digital rendering of the framework was 
evaluated in relation to the planned tooth-positions and arch shape defined by the 
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patients duplicated maxillary denture. This provided improved utilization and 
distribution of available restorative space between the prosthetic framework and the 
acrylic veneer/prosthetic teeth. The authors hypothesize that this methodology 
helped the design and fabrication of a robust prosthesis.  
Prosthodontic Planning: Cantilevers and A-P Spread 
The prosthodontic treatment planning goals included maximization of A-P spread, 
minimizing cantilever and providing minimal vertical anterior overlap / shallow 
anterior guidance. Individual measurements and mean values of A-P spread, 
cantilever values, anterior vertical and horizontal overlaps that were achievable for 8 
patients that received their definitive ISFP were provided. The authors hypothesize 
that these factors may reduce fatigue and stress on the abutment/screw/prosthesis 
assembly and reduce the frequency of fractures/chipping of the anterior acrylic teeth 
which is one of the common complications reported.(22,23,35). In the present study, 
the ratio of posterior cantilever length to A-P spread was 0.6 bilaterally (Table 4.1), 
significantly less than what has been proposed (26,27). By extension, this may 
enable increased cantilever values while maintaining an acceptable Cantilever/A-P 
Spread ratio if required.  
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Table 4.1: Ratios of Posterior Cantilever to A-P spread 
 
Ratios Posterior Cantilever to A-P Spread 
Patient ID # RIGHT LEFT 
1 0.7 0.9 
2 0.1 0.1 
3 0.9 0.8 
4 0.9 0.8 
5 
  6 0.2 0.2 
7 
  8 0.4 0.5 
9 1.2 0.9 
10 0.7 1.0 
Mean Ratio 0.6 0.6 
 
Strengths and limitations 
Limitations 
This study investigated the safety, potential and feasibility of a new treatment 
modality incorporating the use of a perceived small number (4) of implants as well as 
the strategic use of implant as short as 6 mm. It was a pilot study on a small sample 
of patients (n=10). As such, the implant and prosthetic data are descriptive and 
explanatory with no statistical significance. During the clinical trial, problems of early 
implant loss were experienced with some patients prior to prosthesis loading. This 
may suggest that perhaps bone grafting to augment the implant sites prior to 
placement were needed on these patients. The study was short term and more long-
term data is required before any conclusive recommendations may be presented on 
this treatment modality.  
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Strengths 
This was a prospective study that sought to expand the application of fixed implant 
rehabilitations in the edentulous maxilla. If non-anatomic (financial limitations, 
medical, age, fear) exclusion criteria were not applied, altogether 19 of the 36 
patients (52.8%) initially screened could have been included in this study. This may 
suggest that a high percentage of edentulous maxillas could be treated with a 
simplified protocol. Minimal prosthetic complications were experienced and were 
easily manageable at the same appointment. No patients were lost to follow-ups 
during the study and no implant losses were experienced after prosthesis delivery.  
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5 CONCLUSION 
i. Short implant placement and support of maxillary ISFD using four short 
implants is possible in select patients, but with caution, due to lack of long-
term follow up at 1 and 5 years to determine implant survival and prosthetic 
complications.  
ii. Short implant in the posterior maxilla may allow a reduction of posterior 
cantilever by engaging more posterior sites without grafting.  
iii. Short implants in the premaxilla allows lingual and quasi-axial placement 
within the protruding ridge compared to longer implants of equal diameter. 
This may facilitate prosthetic design and conception.  
iv. All Implant failures occurred prior to prosthesis delivery (preloading) and were 
predominantly in pre-maxillary sites.  
v. No implant loss was reported after prosthesis delivery in 8 patients.  
vi. CAD/CAM Cobalt-Chrome Framework technology offers several advantages 
including fidelity of design, goodness of fit and high modulus of elasticity.  
vii. Prosthetic complications were minimal and easily managed.  
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PART TWO: ORAL HEALTH & QUALITY OF LIFE 
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1 INTRODUCTION 
1.1 Prevalence and scope of edentulism 
Edentulism is unfortunately still a prevalent disability among the older-age group. 
The percentage of complete edentulism has been estimated to be 26% for people 
more than 65 years of age in the USA (39). In 2002, Douglass et al. stated that the 
prevalence of edentulism dropped by approximately 10% for each decade of the 
past 30 years in the United States(1), yet, because of population growth, especially 
in older age group, an increase in the number of edentulous patients can be 
expected. The total need for treatment of edentulism will rise in the next 10 years. 
Therefore, the need for complete dentures will continue to increase through the year 
2020.  
More recently, complete edentulism has been described as the terminal outcome of 
a multi-factorial process involving biological factors and patient-related factors. It 
continues to represent a tremendous global health care burden, and will for the 
foreseeable future. Furthermore, systemic and oro-facial comorbid factors 
associated with complete edentulism have also been discussed (2).  
 
1.2 Quality of life and complete dentures 
A recent review article(40) found that despite the best efforts of dentists, there 
seems to be a small but ever existent group of complete denture wearers who 
remain dissatisfied despite the provision of technically correct dentures. Several 
authors who have attempted to quantify the proportion of the edentulous population 
that may be non-adaptive were included in the review paper.  
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The results are summarized in table 1-2-1.  
 
Table 1-2-1: Residual dissatisfied patients with complete dentures 
            Author  Residual Dissatisfied Patients  
Al Quran et al.                  2001 (41) 16 %  
Berg et al.                        1984(42)  10 – 15 %, Mandible > Maxilla  
Bergman & Carlsson       1972(43)  10 – 15%  
Celebic et al.                   2003(44)  7.2 %  
Magnusson                     1986(45)  10 %  
Van Waas                      1990(46)  Maxilla: 10 %, Mandible: 21 %  
 
 
1.3 Rationale for ISFP’s in the edentulous maxilla 
A prospective clinical study (47) comparing the treatment outcomes of fixed and 
removable implant-supported prostheses in the edentulous maxilla emphasized the 
patient‟s point of view. 20 patients were included and 10 patients received a fixed 
prosthesis and 10 patients a removable overdenture. A visual analogue scale was 
administered to the patients to evaluate patients‟ assessments of their treatment. 
Patients in both groups were similarly satisfied with regard to their well-being and 
cost-utility irrespective of whether their implant-supported prosthesis was fixed or 
removable. 
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A retrospective study of 62 patients to assess patient satisfaction and oral health 
related quality of life (OHQOL) outcomes of implant overdentures and fixed complete 
dentures, Brennan et al.(48) has shown high satisfaction for both groups. Of the 62 
patients 9 had maxillary ISFP‟s and 22 maxillary implant-supported overdentures. 
Using the OHIP-14(49) instrument, the authors concluded that overall OHQOL was 
high, however, the ISFP group demonstrated significantly lower psychological 
discomfort and disability compared to the removable overdenture group. Also, 
among the patients receiving similar number of implants, those who received an 
implant overdenture were less satisfied and had a lower OHQOL that those with an 
ISFP.  
When provided with a choice between removable and fixed restorations in the 
edentulous maxilla, some patients have elected to have a fixed prosthesis. 
Heydecke et al.(50) studied 13 subjects edentulous in the maxilla in a within-subject 
comparison of fixed versus removable implant-supported maxillary prostheses. The 
aim was to assess patients‟ satisfaction and choice of prosthesis. 8 and 5 subjects 
were initially provided with a fixed and removable implant-supported maxillary 
prosthesis respectively. The prostheses were then switched for removable and fixed 
respectively after 2 months of wear. The patients were then asked to choose which 
prosthesis they wanted to keep. 4 of 13 decided to keep the fixed prosthesis. It 
appears that some patients would prefer to have an ISFP in the maxilla when given 
the choice.  
These three studies present some evidence that both removable and fixed implant 
supported prostheses in the edentulous maxilla may provide satisfaction and 
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OHQOL to patients. Some patients when given the choice, prefer a fixed prosthesis. 
It is possible in some patients that an ISFP may provide superior OHQOL and lower 
psychological disability when compared to a removable implant-supported 
prosthesis.  
Therefore, there seems to be a good rationale to provide ISFP‟s to some patients 
that may desire and benefit from such therapy. It is important that, when possible, 
treatment plans for implant therapy in the edentulous maxilla should include both 
modalities – fixed and removable.  
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2 MATERIALS AND METHODS 
2.1 Patient selection 
Patient seeking implant therapy for the edentulous maxilla who had interest or were 
potentially in need of a maxillary ISFP were asked to contact the investigators 
regarding possible enrollment in the study protocol. Potential patients were offered a 
screening appointment in the Graduate Prosthodontic Clinic at the School of 
Dentistry of the University of North Carolina at Chapel Hill (UNC-CH).  
Table 2-1-1: Demographic Characteristics for enrolled subjects.  
Characteristic   Statistic Subjects (N=10) 
   
Age   Mean    62.1 
   Min, Max    39.3, 78.3 
Gender    
        Male   N (%) 3 (30%) 
        Female   N (%) 7 (70%) 
Race   
        Caucasian                        N (%) 8 (80%) 
        African-American   N (%) 2 (20%) 
   
 
Altogether, 36 patients (16 men and 20 women) were screened. Consecutive 
enrollment of 10 patients fulfilling all inclusion criteria was completed over a period of 
five months from May to September 2009. A screening questionnaire (Appendix B) 
was used to assist in recruitment. Reasons for exclusion were mostly due to 
anatomic limitations, financial, medical or patient‟s choice. The details of inclusion 
and exclusion was presented in part one. The aim of this study was to assess the 
impact of an ISFP in the edentulous maxilla on the OHQOL and satisfaction 
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compared to baseline values. The OHIP-49 instrument (19) was utilized for this 
assessment. The patients‟ demographic information is summarized in table 2-1-1.  
 
2.2 From complete dentures to ISFP’s 
The study was a prospective clinical trial involving treatment of patients edentulous 
in the maxilla with a definitive maxillary metal-acrylic implant supported fixed 
prosthesis (ISFP). Through a series of 15 appointments described in part one, the 
10 enrolled subjects underwent the same protocol for treatment over a period of 15 
to 18 months. One patient did not complete the protocol because of early failure of 
all initial implants and therefore could not receive her final ISFP.  
The treatment protocol is chronologically outlined below: 
- Screening, enrollment, examination, initial records and consent 
- Baseline administration of OHIP-49 
- Fabrication of ideal maxillary complete denture 
- Treatment planning of Implant therapy and ISFP 
- Implant placement (surgery)  
- Following implant integration, abutment connections and impressions for 
ISFP fabrication 
- Delivery of ISFP 
- 1 to 2 weeks post-delivery of ISFP and administration of OHIP-49 
- 6 months post-delivery of ISFP and administration of OHIP-49 
- 12 months post-delivery of ISFP and administration of OHIP-49 
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2.3 The Oral Health Impact Profile (OHIP-49) instrument 
Guckes et al. presented a conceptual framework for understanding outcomes of oral 
implant therapy. This framework addressed four major required concepts: safety, 
efficacy, effectiveness and outcomes. In the treatment outcomes, the authors 
suggest that one should understand longevity/survival, physiologic impact, 
psychologic impact, and finally economic impact. The main aim of the present study 
was to assess the physiologic and psychologic impact of the maxillary ISFP 
treatment modality on a group of 10 patients. Physiologic and psychologic impact 
include masticatory efficiency, bite force, maintenance of bone, effect of treatment 
on diet/nutrition, oro-facial body image, perceived satisfaction with prosthesis, self-
esteem and interpersonal relations.  
The ultimate goal of implant therapy is the improved OHQOL of the patient receiving 
care. An instrument for evaluating OHQOL is the Oral Health Impact Profile – 49. 
This is a self-administered 49 item questionnaire that assesses theoretical subscales 
or dimension of the adverse oral health adapted by Locker from the1980 World 
Health Organization International Classification of Impairments, Disabilities and 
Handicaps (ICIDH). The subscale categories are functional limitation, physical pain, 
psychological discomfort, physical disability, psychological disability and 
handicap.(19,51) 
 
2.4 Data collection 
The OHIP-49 questionnaire was administered to the patients at 4 time points: 
- 1. Baseline: prior to any treatment upon enrollment 
64 
 
- 2. One to two weeks after final delivery of ISFP 
- 3. Six months after final delivery of ISFP 
- 4. Twelve months after final delivery of ISFP (not available at time of 
reporting).  
At the time of reporting, 10 patients provided completed questionnaires at baseline. 
7 patients provided completed questionnaires at one to two weeks after final delivery 
of ISFP and 7 patients provided completed questionnaires for six months after final 
delivery of ISFP. The OHIP-49 data was input on an excel file by the investigator 
and verified by another person prior to statistical analysis.  
 
2.5 Methods 
The OHIP-49 questionnaire measures the adverse consequences of oral disorders 
on different aspects of quality of life.(19)  Each of 49 items asks respondents how 
often they have experienced an adverse impact within a specified time interval. 
Responses are made on an ordinal scale ranging from “never” (coded 0), “hardly 
ever” (coded 1), “occasionally” (coded 2), “fairly often” (coded 3) to “very often” 
(coded 4). The summary variable used in this analysis was the severity score 
computed as the sum of ordinal responses across all items.(52) This yields a 
potential range of zero to 192, with higher scores indicating poorer oral health quality 
of life. The OHIP-49 typically yields low severity scores since the questionnaire 
intentionally captures only severe adverse impacts. In the few instances where 
responses were missing or the response was marked “don‟t know”, the sample 
mean for that item was substituted.  
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2.6 Analytic Methods 
The small number of observations violated the assumption of normally distributed 
OHIP-49 scores and precluded use of parametric methods. Instead, the Wilcoxon 
signed-ranks test performed a non-parametric analog of the paired Student‟s t test.  
Consistent with this test, median OHIP-49 severity scores were reported as the 
measure of central tendency with the interquartile range (IQR) acting as the 
measure of dispersion. Analysis compared a patient‟s OHIP-49 severity score at 
baseline against their OHIP-49 score reported 1−2 weeks post prosthetic delivery. 
Also compared were paired scores at 1−2 weeks and six months post delivery.  
The null hypothesis stated that the paired scores, when ranked, were the same at 
each time point. The P-value describes the difference in the distribution of ranked 
paired-scores, as opposed to a difference in the median values themselves. A two-
tailed P-value of less than 0.05 was considered adequate to reject the null 
hypothesis; and hence indicate a statistically significant difference in the paired 
observations. To identify in which dimensions were associated with changes in 
OHIP-49 after treatment, each of the seven OHIP dimensions was separately 
examined. Analysis was conducted using Stata software, release 11.1 (StataCorp. 
2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP). 
 
3 RESULTS 
All 10 patients completed the OHIP-49 questionnaire at baseline. Because two 
patients did not complete the questionnaire at the 1−2 week visit, statistical analysis 
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was confined to those with paired data (n=8). Baseline OHIP-49 severity scores 
ranged from a low of 12 to a high of 137 with a median value of 72 (IQR 44, 103). At 
1-2 weeks post prosthetic delivery, these scores had fallen substantially, now 
ranging from 8 to 24 with a median value of 13 (IQR 9, 11) (P-value =0.0173), 
permitting rejection of the null hypothesis (results not tabulated).  
Table 3-1: Absolute OHIP-49 severity score recorded at baseline and at two points post 
prosthetic delivery 
Patient 
# 
Baseline  
OHIP-49  
severity score  
1-2 week  
OHIP-49  
severity score  
6 month  
OHIP-49  
severity score  
1 89 8 11 
2 12 13 4 
3 117 9 6 
4 36 10 3 
6 57 20 11 
8 137 24 … 
9 52 12 10 
10 86 19 8 
 
Among the 7 patients with data at all three time-points, OHIP-49 severity scores 
decreased for all but patient #1 who reported a small increase at the six-month visit. 
The magnitude of effect was immense. It ranged from a three-fold decrease in 
adverse impacts for patient #2 to a 20-fold reduction in impacts for patient #3 (Table 
3-1). 
OHIP-49 data from the 6-month visit were obtained for seven patients. Further small 
reductions in OHIP-49 scores were observed at this time. The range of distribution 
was 3-11 with a median of 8 (IQR 4, 11). In comparison with scores obtained at the 
1-2 week visit, these 6 months scores were lower, but the difference failed to reach 
statistical significance (P= 0.0630)(Figure 3-3).  
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To identify the subscale on which greatest gains in oral health quality of life were 
achieved, scores on each of the seven subscales were examined at the three time 
points.  OHIP scores fell significantly on all seven dimensions for every patient 
between baseline and the 1-2 week post delivery visit (Table 3-2). In absolute terms, 
greatest reduction occurred on the functional limitation subscale. These items (#1-
#9) deal with factors such as chewing ability, speech, food catching and denture fit.  
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Table 3-2: Median OHIP severity scores (interquartile range) for the overall OHIP-49 
questionnaire and its seven subscales at baseline, 1-2 weeks post prosthetic delivery, six-
month post prosthetic delivery 
 
Baseline 
 1-2 week post  
delivery 
  
 Medi
an 
(IQR)  Median (IQR) 
P-value 
(a)
 
 
OHIP-49 severity score  
(items #1-49) 
72 (44, 103)  13 (9, 20) 0.0173  
Functional limitation (items #1−9) 18 (12, 28)  5 (5, 7) 0.0173  
Physical pain (items #10−18) 14 (8, 20)  3 (2, 3) 0.0117  
Psychological discomfort  
(items #19−23) 
12 (6, 14)  1 (0, 3) 0.0170  
Physical disability (items #24−32) 13 (10, 20)  4 (2, 5) 0.0173  
Psychological disability  
(items #33−38) 
7 (4, 12)  0 (0, 1)  0.0140  
Social disability (items #39−43) 4 (1, 8)  0 (0, 1) 0.0193  
Handicap (items #44−49) 2 (1, 9)  0 (0, 1) 0.0193  
 
Table 3-2 (continued) 
6 months post  delivery  
Median (IQR) P-value 
(b)
  
8 (4, 11) 0.0630 
3 (3, 6) 0.1255 
1 (0, 2) 0.1669 
0 (0, 0) 0.0496 
2 (0, 0) 0.2008 
0 (0, 0) 0.1585 
0 (0, 0) 0.3173 
0 (0, 0) 0.1585 
(a) P-value denotes whether the distribution of ranked paired-scores differs at 1-2 weeks from 
baseline  
(b) P-value denotes whether the distribution of ranked paired-scores differs at 6 months from 1-2 
weeks  
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Fig 3-3: Median OHIP-49 severity score and interquartile range at baseline (n=8), and at 1−2 
weeks (n=8) and 6 months (n=7) post prosthesis delivery. Reductions in OHIP severity scores 
from their baseline levels were statistically significant at 1−2 weeks post prosthetic delivery 
(P= 0.0173). The difference in OHIP-49 scores between the 1−2 weeks and 6 month visits failed 
to reach significance (P= 0.0630) 
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4 DISCUSSION 
It was shown that 96 % of patients experience an improvement in OHQoL following 
treatment with fixed, removable and complete dentures. However, after treatment, 
patients receiving removable or complete removable prosthodontics had poorer 
OHQoL that did patients receiving fixed prosthodontic treatment. (53) 
An ISFP is considered a fixed prosthodontic treatment. An alternative to ISFP‟s is 
the Implant-supported Removable Overdenture. Patients receiving treatment with an 
ISFP or ISRO may experience similar satisfaction provided similar specific indication 
criteria are carefully assessed by the clinician.(7,47) 
Although, a majority of patients (9 of 13) in previously described study(50) preferred 
to keep their ISRO when given the choice between an ISFP and an ISRO after 
having used and experienced both prostheses for a period of 2 months each.  
In the present study, within two weeks of ISFD delivery, clinically meaningful and 
statistically significant reductions in median OHIP-49 scores were observed, 
signifying a dramatic improvement in OHQoL. These post treatments OHIP scores 
were similar to those of healthy dentate adults in the US population. At six months 
post-treatment, these gains were maintained in all patients. 
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5 CONCLUSION 
i. This was a prospective clinical study with a small sample size of 10 patients 
to investigate the impact of 4-Implant supported fixed prostheses (ISFP‟s) on 
oral health quality of life (OHQoL) of patients with edentulous maxillae. 
ii. Greatest reduction in OHIP-49 severity scores occurred on the functional 
limitation subscale which deals with factors such as chewing ability, speech, 
food catching and denture fit.  
iii. Maxillary ISFP‟s significantly improved the OHQoL of participants. Post-
treatments OHIP scores were similar to those of healthy dentate adults in the 
US population. 
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